TEST BANK - f f
FOCUS ON NURSING PHARMACOLOGY 9TH E
f f f ff f f
DITION BY AMY KARCH CHAPTER 1-
f f ff f f
59 ISBN 13;978-
f f f
1975180409/ISBN 10;1975180402 COMPLETE GU f f f ff
IDE/ GRADED A+
f f
, 3
Chapter 01- Introduction to Drugs
f f f f
Afnursefworkingfinfradiologyfadministersfiodineftofafpatientfwhofisfhavingfafcomputedftomography(CT)fscan.f
Thefnursefworkingfonfthefoncologyfunitfadministersfchemotherapyftofpatientsfwhofhavefcancer.fAtft
hefPublicfHealthfDepartment,fafnursefadministersfafmeasles-mumps-
rubellaf(MMR)fvaccineftofaf14-month-
oldfchildfasfafroutinefimmunization.fWhichfbranchfoffpharmacologyfbestfdescribesfthefactionsfoffallf
threefnurses?
Pharmacoeconomicsf
Pharmacotherapeuticsf
PharmacodynamicsfP
harmacokineticsfAns:
B
Feedback:
Pharmacologyfisfthefstudyfoffthefbiologicfeffectsfoffchemicals.fNursesfarefinvolvedfwithfclinicalfpharmac
ologyforfpharmacotherapeutics,fwhichfisfafbranchfoffpharmacologyfthatfdealsfwithfthefusesfoffdrugsftoftreat,fp
revent,fandfdiagnosefdisease.fThefradiologyfnursefisfadministeringfafdrugftofhelpfdiagnosefafdisease.fThef
oncologyfnursefisfadministeringfafdrugftofhelpftreatfafdisease.
Pharmacoeconomicsfincludesfanyfcostsfinvolvedfinfdrugftherapy.fPharmacodynamicsfinvolvesfhowfafdr
ugfaffectsfthefbodyfandfpharmacokineticsfisfhowfthefbodyfactsfonfthefbody.
Afphysicianfhasforderedfintramuscularf(IM)finjectionsfoffmorphine,fafnarcotic,feveryf4fhoursfasfneededforfpainf
infafmotorfvehiclefaccidentfvictim.fThefnursefisfawarefthisfdrugfhasfafhighfabusefpotential.fUnderfw
hatfcategoryfwouldfmorphinefbefclassified?
SchedulefIfS
chedulefIIfSc
hedulefIIIfSc
hedulefIVfAn
s: B
Feedback:
Narcoticsf withfaf highf abusef potentialf aref classifiedf asf Schedulef IIfdrugsf becausef offseveref dependence
, 4
liability.fSchedulefIfdrugsfhavefhighfabusefpotentialfandfnofacceptedfmedicalfuse.fSchedulefIIIfdrugsfhavef
aflesserfabusefpotentialfthanfIIfandfanfacceptedfmedicalfuse.fSchedulefIVfdrugsfhaveflowfabusefpotential
fandflimited fdependence fliability.
WhenfinvolvedfinfphasefIIIfdrugfevaluationfstudies,fwhatfresponsibilitiesfwouldfthefnursefhave?fWork
ingfwithfanimalsfwhofarefgivenfexperimentalfdrugs
ChoosingfappropriatefpatientsftofbefinvolvedfinfthefdrugfstudyfMonit
oringfandfobservingfpatientsfcloselyfforfadversefeffectsfConductingfre
searchftofdeterminefeffectivenessfoffthefdrugAns:f C
Feedback:
PhasefIIIfstudiesfinvolvefusefoffafdrugfinfafvastfclinicalfpopulationfinfwhichfpatientsfarefaskedftofrecordfanyfs
ymptomsftheyfexperiencefwhileftakingfthefdrugs.fNursesfmayfbefresponsiblefforfhelpingfcollectfandfanal
yzefthefinformationftofbefsharedfwithfthefFoodfandfDrugfAdministrationf(FDA)fbutfwouldfnotfconductfres
earchfindependentlyfbecausefnursesfdofnotfprescribefmedications.fUsefoffanimalsfinfdrugftestingfisfdonef
infthefpreclinicalftrials.fSelectfpatientsfwhofarefinvolvedfinfphasefIIfstudiesftofparticipatef infstudiesfwherefth
efparticipantsfhavefthefdiseasefthefdrugfisfintendedftoftreat.fThesefpatientsfarefmonitoredfcloselyfforfdrugf
actionfandfadversefeffects.fPhasefIfstudiesfinvolvefhealthyfhumanfvolunteersfwhofarefusuallyfpaidfforftheirfp
articipation.fNursesfmayfobservefforfadversefeffectsfandftoxicity.
Whatfconceptfisfconsideredfwhenfgenericfdrugsfarefsubstitutedfforfbrandfnamefdrugs?fBioavailability
Criticalfconcentrationf
Distribution
Half-
lifefAns: A
Feedback:
Bioavailabilityfisfthefportionfoffafdosefoffafdrugfthatfreachesfthefsystemicfcirculationfandfisfavailableftofactfon
fbodyfcells.fBinders fusedfinfafgenericfdrugfmayfnotfbefthefsamefasfthosefusedfinfthefbrandfnamefdrug. fTher
efore,fthefwayfthefbodyfbreaksfdownfandfusesfthefdrugfmayfdiffer,fwhichfmayfeliminatefafgenericfdrugfs
ubstitution.fCriticalfconcentrationfisfthefamountfoffafdrugfthatfisfneededftofcausefaftherapeuticfeffectfandf
shouldfnotfdifferfbetweenfgenericfandfbrandfnamefmedications.fDistributionfisfthefphasefoffpharmacoki
netics,fwhichfinvolvesfthefmovementfoffafdrugftofthefbody’sftissuesfandfisfthe
, 5
samefinfgenericfandfbrandfnamefdrugs.fAfdrug’sfhalf-
lifefisftheftimefitftakesfforfthefamountfoffdrugftofdecreaseftofhalffthefpeakflevel,fwhichfshouldfnotfchangefwh
enfsubstitutingfafgenericfmedication.
Afnursefisfassessingfthefpatient’sfhomefmedicationfuse.fAfterflisteningftofthefpatientflistfcurrentfmedic
ations,fthefnursefasksfwhatfpriorityfquestion?
Dofyouftakefanyfgenericfmedications?
Arefanyf off thesef medicationsf orphanf drugs?
Arefthesefmedicationsfsafeftoftakefduringfpregnancy?fD
ofyouftakefanyfover-the-counterfmedications?
Ans: D
Feedback:
Itfisfimportantfforfthefnurseftofspecificallyfquestionfusefoffover-the-
counterfmedicationsfbecausefpatientsfmayfnotfconsiderfthemfimportant.fThefpatientfisfunlikelyftofknowfthefm
eaningfofforphanfdrugsfunlessftheyftoofarefhealthfcarefproviders.fSafetyfduringfpregnancy,fusefoffafgenericf
medication,forfclassificationfofforphanfdrugsfarefthingsfthefpatientfwouldfbefunableftofanswerfbutfcouldfb
effoundfinfreferencefbooksfiffthefnursefwishesftofresearchfthem.
Afterfcompletingfafcoursefonfpharmacologyfforfnurses,fwhatfwillfthefnursefknow?fEverythingfn
ecessaryfforfsafefandfeffectivefmedicationfadministration
Currentfpharmacologicftherapy;fthefnursefwillfnotfrequirefongoingfeducationfforf5fyears.fGe
neralfdrugfinformation;fthefnursefcanfconsultfafdrugfguidefforfspecificfdrugfinformation.fThefdr
ugfactionsfthatfarefassociatedfwithfeachfclassificationfoffmedicationAns: C
Feedback:
Afterfcompletingfafpharmacologyfcoursefnursesfwillfhavefgeneralfdrugfinformationfneededfforfsafefandfeffec
tivefmedicationfadministrationfbutfwillfneedftofconsultfafdrugfguidefforfspecificfdrugfinformationfbeforefa
dministeringfanyfmedication.fPharmacologyfisfconstantlyfchanging,fwithfnewfdrugsfenteringfthefmarket
fandfnewfusesfforfexistingfdrugsfidentified. fContinuing feducation finfpharmacology fisfessentialftofsafefpr
actice.fNursesftendftofbecomeffamiliarfwithfthefmedicationsftheyfadministerfmostfoften,fbutftherefwillfal
waysfbefafneedftofresearchfnewfdrugsfandfalsofthosefthefnursefisfnotffamiliarfwithfbecausefnofnursefknowsfa
llfmedications.
FOCUS ON NURSING PHARMACOLOGY 9TH E
f f f ff f f
DITION BY AMY KARCH CHAPTER 1-
f f ff f f
59 ISBN 13;978-
f f f
1975180409/ISBN 10;1975180402 COMPLETE GU f f f ff
IDE/ GRADED A+
f f
, 3
Chapter 01- Introduction to Drugs
f f f f
Afnursefworkingfinfradiologyfadministersfiodineftofafpatientfwhofisfhavingfafcomputedftomography(CT)fscan.f
Thefnursefworkingfonfthefoncologyfunitfadministersfchemotherapyftofpatientsfwhofhavefcancer.fAtft
hefPublicfHealthfDepartment,fafnursefadministersfafmeasles-mumps-
rubellaf(MMR)fvaccineftofaf14-month-
oldfchildfasfafroutinefimmunization.fWhichfbranchfoffpharmacologyfbestfdescribesfthefactionsfoffallf
threefnurses?
Pharmacoeconomicsf
Pharmacotherapeuticsf
PharmacodynamicsfP
harmacokineticsfAns:
B
Feedback:
Pharmacologyfisfthefstudyfoffthefbiologicfeffectsfoffchemicals.fNursesfarefinvolvedfwithfclinicalfpharmac
ologyforfpharmacotherapeutics,fwhichfisfafbranchfoffpharmacologyfthatfdealsfwithfthefusesfoffdrugsftoftreat,fp
revent,fandfdiagnosefdisease.fThefradiologyfnursefisfadministeringfafdrugftofhelpfdiagnosefafdisease.fThef
oncologyfnursefisfadministeringfafdrugftofhelpftreatfafdisease.
Pharmacoeconomicsfincludesfanyfcostsfinvolvedfinfdrugftherapy.fPharmacodynamicsfinvolvesfhowfafdr
ugfaffectsfthefbodyfandfpharmacokineticsfisfhowfthefbodyfactsfonfthefbody.
Afphysicianfhasforderedfintramuscularf(IM)finjectionsfoffmorphine,fafnarcotic,feveryf4fhoursfasfneededforfpainf
infafmotorfvehiclefaccidentfvictim.fThefnursefisfawarefthisfdrugfhasfafhighfabusefpotential.fUnderfw
hatfcategoryfwouldfmorphinefbefclassified?
SchedulefIfS
chedulefIIfSc
hedulefIIIfSc
hedulefIVfAn
s: B
Feedback:
Narcoticsf withfaf highf abusef potentialf aref classifiedf asf Schedulef IIfdrugsf becausef offseveref dependence
, 4
liability.fSchedulefIfdrugsfhavefhighfabusefpotentialfandfnofacceptedfmedicalfuse.fSchedulefIIIfdrugsfhavef
aflesserfabusefpotentialfthanfIIfandfanfacceptedfmedicalfuse.fSchedulefIVfdrugsfhaveflowfabusefpotential
fandflimited fdependence fliability.
WhenfinvolvedfinfphasefIIIfdrugfevaluationfstudies,fwhatfresponsibilitiesfwouldfthefnursefhave?fWork
ingfwithfanimalsfwhofarefgivenfexperimentalfdrugs
ChoosingfappropriatefpatientsftofbefinvolvedfinfthefdrugfstudyfMonit
oringfandfobservingfpatientsfcloselyfforfadversefeffectsfConductingfre
searchftofdeterminefeffectivenessfoffthefdrugAns:f C
Feedback:
PhasefIIIfstudiesfinvolvefusefoffafdrugfinfafvastfclinicalfpopulationfinfwhichfpatientsfarefaskedftofrecordfanyfs
ymptomsftheyfexperiencefwhileftakingfthefdrugs.fNursesfmayfbefresponsiblefforfhelpingfcollectfandfanal
yzefthefinformationftofbefsharedfwithfthefFoodfandfDrugfAdministrationf(FDA)fbutfwouldfnotfconductfres
earchfindependentlyfbecausefnursesfdofnotfprescribefmedications.fUsefoffanimalsfinfdrugftestingfisfdonef
infthefpreclinicalftrials.fSelectfpatientsfwhofarefinvolvedfinfphasefIIfstudiesftofparticipatef infstudiesfwherefth
efparticipantsfhavefthefdiseasefthefdrugfisfintendedftoftreat.fThesefpatientsfarefmonitoredfcloselyfforfdrugf
actionfandfadversefeffects.fPhasefIfstudiesfinvolvefhealthyfhumanfvolunteersfwhofarefusuallyfpaidfforftheirfp
articipation.fNursesfmayfobservefforfadversefeffectsfandftoxicity.
Whatfconceptfisfconsideredfwhenfgenericfdrugsfarefsubstitutedfforfbrandfnamefdrugs?fBioavailability
Criticalfconcentrationf
Distribution
Half-
lifefAns: A
Feedback:
Bioavailabilityfisfthefportionfoffafdosefoffafdrugfthatfreachesfthefsystemicfcirculationfandfisfavailableftofactfon
fbodyfcells.fBinders fusedfinfafgenericfdrugfmayfnotfbefthefsamefasfthosefusedfinfthefbrandfnamefdrug. fTher
efore,fthefwayfthefbodyfbreaksfdownfandfusesfthefdrugfmayfdiffer,fwhichfmayfeliminatefafgenericfdrugfs
ubstitution.fCriticalfconcentrationfisfthefamountfoffafdrugfthatfisfneededftofcausefaftherapeuticfeffectfandf
shouldfnotfdifferfbetweenfgenericfandfbrandfnamefmedications.fDistributionfisfthefphasefoffpharmacoki
netics,fwhichfinvolvesfthefmovementfoffafdrugftofthefbody’sftissuesfandfisfthe
, 5
samefinfgenericfandfbrandfnamefdrugs.fAfdrug’sfhalf-
lifefisftheftimefitftakesfforfthefamountfoffdrugftofdecreaseftofhalffthefpeakflevel,fwhichfshouldfnotfchangefwh
enfsubstitutingfafgenericfmedication.
Afnursefisfassessingfthefpatient’sfhomefmedicationfuse.fAfterflisteningftofthefpatientflistfcurrentfmedic
ations,fthefnursefasksfwhatfpriorityfquestion?
Dofyouftakefanyfgenericfmedications?
Arefanyf off thesef medicationsf orphanf drugs?
Arefthesefmedicationsfsafeftoftakefduringfpregnancy?fD
ofyouftakefanyfover-the-counterfmedications?
Ans: D
Feedback:
Itfisfimportantfforfthefnurseftofspecificallyfquestionfusefoffover-the-
counterfmedicationsfbecausefpatientsfmayfnotfconsiderfthemfimportant.fThefpatientfisfunlikelyftofknowfthefm
eaningfofforphanfdrugsfunlessftheyftoofarefhealthfcarefproviders.fSafetyfduringfpregnancy,fusefoffafgenericf
medication,forfclassificationfofforphanfdrugsfarefthingsfthefpatientfwouldfbefunableftofanswerfbutfcouldfb
effoundfinfreferencefbooksfiffthefnursefwishesftofresearchfthem.
Afterfcompletingfafcoursefonfpharmacologyfforfnurses,fwhatfwillfthefnursefknow?fEverythingfn
ecessaryfforfsafefandfeffectivefmedicationfadministration
Currentfpharmacologicftherapy;fthefnursefwillfnotfrequirefongoingfeducationfforf5fyears.fGe
neralfdrugfinformation;fthefnursefcanfconsultfafdrugfguidefforfspecificfdrugfinformation.fThefdr
ugfactionsfthatfarefassociatedfwithfeachfclassificationfoffmedicationAns: C
Feedback:
Afterfcompletingfafpharmacologyfcoursefnursesfwillfhavefgeneralfdrugfinformationfneededfforfsafefandfeffec
tivefmedicationfadministrationfbutfwillfneedftofconsultfafdrugfguidefforfspecificfdrugfinformationfbeforefa
dministeringfanyfmedication.fPharmacologyfisfconstantlyfchanging,fwithfnewfdrugsfenteringfthefmarket
fandfnewfusesfforfexistingfdrugsfidentified. fContinuing feducation finfpharmacology fisfessentialftofsafefpr
actice.fNursesftendftofbecomeffamiliarfwithfthefmedicationsftheyfadministerfmostfoften,fbutftherefwillfal
waysfbefafneedftofresearchfnewfdrugsfandfalsofthosefthefnursefisfnotffamiliarfwithfbecausefnofnursefknowsfa
llfmedications.
